NCT00036140已完成1 期
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Pfizer
- 试验地点
- 6
研究概览
简要总结
The primary goal of the study is to determine the best dose of an investigational drug to give to patients with multiple myeloma and to evaluate the investigational drug's effectiveness as a treatment for multiple myeloma.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Eligible patients must be at least 18 years of age with a diagnosis of multiple myeloma including elevated M-blood/urine protein or a tumor that can be evaluated by the doctor during the investigational drug's treatment.
- •The patient's multiple myeloma must have gotten worse during/after previous chemotherapy was given.
- •Any side-effects from prior chemotherapy must have subsided
- •Blood and urine tests must show adequate bone marrow, liver, and kidney function.
排除标准
- •Any of the following will exclude patients from study participation:
- •indolent or smoldering myeloma or localized plasmacytoma
- •hyperviscosity syndrome
- •irradiation to 25% or more of bone marrow
- •prior high dose chemotherapy with bone marrow or stem cell support
- •current participation in other clinical trials
- •pregnant or breast-feeding women
- •known HIV-positive or AIDS-related illness
- •patients planning to have radiation therapy or surgery that would interrupt study therapy in the next 6 months.
研究者
研究点 (6)
Loading locations...
相似试验
已完成
2 期
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye DiseaseDry Eye DiseaseNCT04084483Kowa Research Institute, Inc.238
招募中
2 期
A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .Renal AnemiaNCT05629598Angde Biotech Pharmaceutical Co., Ltd.150
已完成
2 期
Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)Carcinoma, Non-Small-Cell LungLung NeoplasmsNCT00034957Pfizer
招募中
1 期
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed GlioblastomaGlioblastomaNCT04443010Philogen S.p.A.226
进行中（未招募）
2 期
Adrenomedullin for ischemic stroke studyAcute non-embolic ischemic strokeLacunar stroke, Non-embolic, Acute, Ischemic strokeD002544JPRN-jRCT2051190092IHARA MASAFUMI60